在虚拟CKD患者中,学习启用了控制最佳EPO剂量:出血和错过剂量的情况
概括
强化学习 (RL) 和自适应模型预测控制 (AMPC) 等无模型方法为慢性病 (CKD) 患者提供精确的红素 (EPO) 剂量,即使有出血或错过剂量. DQN-RL是有效的,但数据密集型.
科学领域:
- 生物医学工程 生物医学工程
- 控制系统 控制系统
- 药理学 药理学是指药理学的学科.
背景情况:
- 传统的以模型为基础的血红素 (EPO) 剂量控制在处理患者变异性,模型不确定性和未建模的动态方面面临限制.
- 个性化EPO剂量对于慢性病 (CKD) 患者至关重要,因为治疗窗口狭窄,生理特征非线性,特别是在出血或错过剂量时.
研究的目的:
- 研究无模型强化学习 (RL) 和自适应模型预测控制 (AMPC) 对虚拟CKD患者精确EPO剂量的有效性.
- 评估这些方法在管理复杂的场景,如出血和错过的剂量保持目标血红蛋白水平.
主要方法:
- 开发和培训了一个自适应模型预测控制 (AMPC) 策略和一个基于深度Q网络 (DQN) 的强化学习 (RL) 代理.
- 利用虚拟慢性病 (CKD) 患者模型来模拟和优化红素蛋白 (EPO) 剂量.
- 专注于保持血红蛋白 (Hgb) 水平在10-12g/dL的目标范围内.
主要成果:
- 无论是AMPC还是DQN-RL都证明了能够达到最佳EPO剂量并保持血红蛋白 (Hgb) 水平在所需范围内的能力.
- AMPC提供了有效的控制,而DQN-RL虽然有能力,但提出了更高的计算需求,需要大量的数据进行培训.
- 该研究证实了在复杂的EPO剂量场景中采用无模型方法的可行性.
结论:
- 无模型的RL和AMPC是准确的,个性化的EPO剂量在CKD患者的可行策略,特别是在具有挑战性的情况,如出血或错过剂量.
- 这些先进的控制框架可以支持临床决策,以改善患者管理和治疗结果.
- DQN-RL显示出有希望的结果,但需要进一步优化,以满足临床应用中的计算效率和数据要求.
相关概念视频
Renal Failure: Dose Adjustments
54
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
54
Rational Dosage Regimen: Maintenance Dose and Loading Dose
3.8K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
3.8K
Drug Dosage Regimen: Overview
3.4K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.4K
Nonlinear Pharmacokinetics: Overview
249
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
249
Dosage Regimen: Fixed Dose
1.8K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.8K
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
327
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
On...
327


